iShares Genomics Immunology and Healthcare ETF
IDNA
48 hedge funds and large institutions have $43.7M invested in iShares Genomics Immunology and Healthcare ETF in 2020 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 9 closing their positions.
140% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 5
122% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 9
45% more capital invested
Capital invested by funds: $30.1M → $43.7M (+$13.6M)
30% more funds holding
Funds holding: 37 → 48 (+11)
3.8% more ownership
Funds ownership: 21.14% → 24.94% (+3.8%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$3.36M |
| 2 |
SWM
Strategic Wealth Management
Kirkland,
Washington
|
+$1.75M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.04M |
| 4 |
WAP
Wealthcare Advisory Partners
West Chester,
Pennsylvania
|
+$948K |
| 5 |
LPL Financial
San Diego,
California
|
+$907K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCS
Retirement Capital Strategies
San Jose,
California
|
-$5.99M |
| 2 |
Jane Street
New York
|
-$1.17M |
| 3 |
SFS
Sowell Financial Services
North Little Rock,
Arkansas
|
-$616K |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$314K |
| 5 |
TA
TCG Advisors
Austin,
Texas
|
-$280K |
IDNA Hedge Fund Activity: Q3 2020 in Review
48 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in iShares Genomics Immunology and Healthcare ETF (IDNA) for Q3 2020, worth a combined $43.7M — up 45% from $30.1M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new IDNA positions and 9 closed out — a net gain of 11 holders — while 12 added to existing stakes and 5 trimmed.
The largest buyer was UBS Group, adding an estimated $3.36M. The largest seller was Retirement Capital Strategies, cutting an estimated $5.99M.
- 48 institutional investors held iShares Genomics Immunology and Healthcare ETF (IDNA) as of Q3 2020, up from 37 in Q2 2020.
- Funds reported $43.7M of iShares Genomics Immunology and Healthcare ETF stock for Q3 2020, up 45% quarter-over-quarter.
- 20 funds opened new iShares Genomics Immunology and Healthcare ETF positions in Q3 2020 and 9 closed out, a net change of +11 holders.
- The largest iShares Genomics Immunology and Healthcare ETF buyer in Q3 2020 was UBS Group, an estimated $3.36M added.
- The largest iShares Genomics Immunology and Healthcare ETF seller in Q3 2020 was Retirement Capital Strategies, an estimated $5.99M sold.
Based on aggregated 13F filings for Q3 2020.